Max Franklin Lebow A Medical Corporation is categorized under Health Services in Inglewood, CA and active since 2008.
Max Franklin Lebow A Medical Corporation was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Max F Lebow at the company’s single location by writing to 555 East Hardy St, Inglewood, California CA 90301 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Max Franklin Lebow A Medical Corporation |
| Contact Person: | Max F Lebow |
| Address: | 555 East Hardy St, Inglewood, California 90301 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Max Franklin Lebow A Medical Corporation was started in 2008 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Max F Lebow for inquiries that concern Max Franklin Lebow A Medical Corporation by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Max Franklin Lebow A Medical Corporation can be found at the coordinates 33.949197,-118.347614 as well as the street address 555 East Hardy St in Inglewood, California 90301.
For its online presence, you may visit Max Franklin Lebow A Medical Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.